Pietro Fratta
frattalab.bsky.social
Pietro Fratta
@frattalab.bsky.social
UCL Queen Square Institute of Neurology and The Francis Crick Institute. RNA metabolism and novel translational approaches for ALS/MND, Kennedy's disease and neurodegen.
Reposted by Pietro Fratta
Very excited to share our latest preprint! We looked at loss and gain of function, innervation, reinnervation, and in vivo axonal transport in a FUS-ALS mouse model!

www.biorxiv.org/content/10.1...

@uclqsion.bsky.social @beccasimkin.bsky.social @andrewtosolini.bsky.social @frattalab.bsky.social
June 18, 2025 at 10:48 AM
Reposted by Pietro Fratta
A 🧵 to walk those interested through this paper...
May 16, 2025 at 4:50 PM
Reposted by Pietro Fratta
Our new review on the challenges of modelling TDP-43 pathology in mice is just out:
rdcu.be/ejZ5a
As usual, together with Lizzy Fisher. Thanks to Jose Brito and @lucastaoro.bsky.social from the lab for putting the data together for the comprehensive tables.
Challenges of modelling TDP-43 pathology in mice
rdcu.be
April 30, 2025 at 4:20 PM
Something different from the lab!
We need better ALS biomarkers to minimise size, duration and cost of trials. Muscle MRI could work as it reliably detects progressive atrophy, and correlates with muscle strength loss.
@uclqsion.bsky.social @uclbrainscience.bsky.social
jnnp.bmj.com/content/earl...
Muscle MRI quantifies disease progression in amyotrophic lateral sclerosis
Background and objectives Quantitative and operator-independent biomarkers of disease progression are urgently needed in amyotrophic lateral sclerosis (ALS) research. We assess the potential of skelet...
jnnp.bmj.com
April 6, 2025 at 10:10 AM